Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ALV +9.6%, PSNY +1.5%, SFNC +1%, KNX +0.9%
Other news:
- BZAI +19.7% (new contract with NeoTensr to generate up to $50 mln in revs in first year)
- KURA +15.9% (reports Darlifarnib Plus Cabozantinib demonstrates robust activity in patients with clear cell renal cell carcinoma previously treated with cabozantinib)
- OPRT +4.9% (names new CEO)
- NI +3.7% (new long-term energy agreement with a subsidiary of Alphabet)
- WFG +3.2% (provides update on US Dept of Commerce softwood lumber duties)
- ARLO +2.3% (completes acquisition of Aloe Care Health)
- QGEN +1.5% (to showcase new sample to insight solutions)
- GTLB +1.2% (releases GitLab 18.11)
- FVCB +1.2% (increases dividend)
- TONX +1.2% (names new CEO)
- CSIQ +1.2% (U.S. board invalidates Trina TOPCon patents)
- FSM +1% (renews share buyback program for up to 5% of shares)
- UPB +1% (to present new data from Phase 2 VIBRANT trial of Verekitug at the ATS 2026 International Conference)